Symprove Ltd has over 25 years of experience in research and development (R&D), moving the technology from its original farming roots, and developing it further for human consumption. In 2005, patents were filed for its proprietary delivery system.
Following extensive research, a range of independent testing, and meeting the challenges of all the regulatory bodies for transfer of technology to humans, the company began to market Symprove in 2008.
Symprove Ltd has a purpose-built production facility in Farnham which uses the latest production processes to produce very high purity bacteria cultures. The company continues to grow and its board of directors now includes physicians and industry experts, providing a wealth of experience and knowledge.
The company continues to be research-driven and is constantly striving to support research into gut health and the microbiome.